Epic Sciences will present two posters at at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain. The first poster is an analysis of PD-L1 protein expression on circulating tumor cells (CTCs) from non-small cell lung cancer (NSCLC) patients. The second poster will present data describing the detection of clinically actionable non-small cell lung cancer (NSCLC) biomarkers, including EGFR, KRAS, ALK, MET, RET and ROS1, utilizing both circulating tumor cells (CTC) and circulating free DNA (cfDNA) from a single tube of blood.
Details of the presentation are as follows:
- Date/Time: Wednesday, November 19, 6 pm to 7:30 pm CET
- Title: Characterization of PD-L1 expression in circulating tumor cells (CTCs) of non-small cell lung cancer (NSCLC) patients
- Presenter: R. Dittamore
- Press release
- Click here to learn more about how detecting PD-L1 in circulating tumor cells could improve immunotherapies
- Date/Time: Thursday, Nov. 20, 6 p.m. to 7:30 p.m. CET
- Title: Characterization of molecular targets of therapy in non-small cell lung cancer (NSCLC) utilizing a liquid biopsy
- Presenter: R. Dittamore
- Press release